계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Spirox
company
About
Spirox is a medical device company improving the quality of life for patients suffering from nasal obstruction.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $45M
- Industries
- Biotechnology,Health Care,Medical,Medical Device
- Founded date
- Jan 1, 2011
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Spirox is a California-based medical device company improving the quality of life for patients suffering from nasal obstruction. They are formerly known as Nasoform. Their first product, the LATERA absorbable nasal implant is designed to address one of the most common, yet undertreated, causes of nasal obstruction today, nasal valve collapse (NVC). The company intends to use the funds to complete development, seek US marketing authorization, and initiate product commercialization. Spirox was founded in 2011 and is headquartered in Menlo Park, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$45M
Spirox has raised a total of
$45M
in funding over 2 rounds. Their latest funding was raised on
Mar 15, 2016 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 15, 2016 | Series C | $45M | 1 |
Kohlberg Kravis Roberts
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Spirox is funded by 1 investors.
Kohlberg Kravis Roberts
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kohlberg Kravis Roberts
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
